31 December 2016 in Medical Physics
SHStijn W.T.P.J. Heijmink
+7
Purpose: Tumor localization provides crucial information for radiotherapy dose differentiation treatments, such as focal dose escalation and dose painting by numbers, which aim at achieving tumor control with minimal side effects.Multiparametric (mp‐)MRI is increasingly used for tumor detection and localization in prostate because of its ability to visualize tissue structure and to reveal tumor characteristics. However, it can be challenging to distinguish cancer, particularly in the transition zone. In this study, we enhance the performance of a mp‐MRI‐based tumor localization model by incorporating prior knowledge from two sources: a population‐based tumor probability atlas and patient‐specific biopsy examination results. This information typically would be considered by a physician when carrying out a manual tumor delineation.Materials and methods: Our study involves 40 patients from two centers: 23 patients from the University Hospital Leuven (Leuven), Leuven, Belgium and 17 patients from the Netherlands Cancer Institute (NKI), Amsterdam, the Netherlands. All patients received a mp‐MRI exam consisting of a T2‐weighted, diffusion‐weighted, and dynamic contrast‐enhanced MRI before prostatectomy. Thirty‐one features were extracted for each voxel in the prostate. Among these, 29 were from the multiparametric‐MRI, one was from the population‐based tumor probability atlas and one from the biopsy map. T2‐weighted images of each patient were registered to whole‐mount section pathology slices to obtain the ground truth. The study was validated in two settings: single‐center (training and test sets were from the same cohort); and cross‐center (training and test sets were from different cohorts). In addition, automatic delineations created by our model were compared with manual tumor delineations done by six different teams on a subset of Leuven cohort including 15 patients.Results: In the single‐center setting, mp‐MRI‐based features yielded area under the ROC curves (AUC) of 0.690 on a pooled set of patients from both cohorts. Including prevalence into mp‐MRI‐based features increased the AUC to 0.751 and including all features achieved the best performance with AUC of 0.775. Using all features always showed better results when varying the size of the training set. In addition, its performance is comparable with the average performance of six teams delineating the tumors manually. The error rate using all features was 0.22. The two prior knowledge features ranked among the top four most important features out of the 31 features.In the cross‐center setting, combining all features also yielded the best performance in terms of the mean AUC of 0.777 on the pooled set of patients from both cohorts. In addition, the difference in performance between the single‐center setting and cross‐center setting was not significant.Conclusions: The results showed significant improvements when including prior knowledge features in addition to mp‐MRI‐based features in both single‐ and cross‐center settings.
1 June 2015 in Computer Graphics Forum
Tumors are heterogeneous tissues consisting of multiple regions with distinct characteristics. Characterization of these intra‐tumor regions can improve patient diagnosis and enable a better targeted treatment. Ideally, tissue characterization could be performed non‐invasively, using medical imaging data, to derive per voxel a number of features, indicative of tissue properties. However, the high dimensionality and complexity of this imaging‐derived feature space is prohibiting for easy exploration and analysis ‐ especially when clinical researchers require to associate observations from the feature space to other reference data, e.g., features derived from histopathological data. Currently, the exploratory approach used in clinical research consists of juxtaposing these data, visually comparing them and mentally reconstructing their relationships. This is a time consuming and tedious process, from which it is difficult to obtain the required insight. We propose a visual tool for: (1) easy exploration and visual analysis of the feature space of imaging‐derived tissue characteristics and (2) knowledge discovery and hypothesis generation and confirmation, with respect to reference data used in clinical research. We employ, as central view, a 2D embedding of the imaging‐derived features. Multiple linked interactive views provide functionality for the exploration and analysis of the local structure of the feature space, enabling linking to patient anatomy and clinical reference data. We performed an initial evaluation with ten clinical researchers. All participants agreed that, unlike current practice, the proposed visual tool enables them to identify, explore and analyze heterogeneous intra‐tumor regions and particularly, to generate and confirm hypotheses, with respect to clinical reference data.
1 April 2016 in Radiotherapy and Oncology
To evaluate the impact of GTV-CTV dose differentiation by simulating response of prostate patients to radiotherapy, considering histopathology of prostatectomy specimens. Tumors' cell numbers (N0) and Gleason Scores (GS) were derived from histopathology of 25 specimens. Index lesions and tumors ⩾0.5cm(3) were considered GTV. Satellites <0.5cm(3) constituted the tumor load in the CTV. Each patient's tumor control probability (TCP) was simulated using the linear quadratic model and considering the N0 while assuming either a constant or GS-dependent α and β. 19/25 patients had multi-focal disease. In 11 patients the CTV contained GS 4+3 or 4+4 tumors. Compared to the GTV, the CTV pathology was more favorable. For an α=0.140Gy(-1), a GTV dose of 79Gy with a CTV dose of 72Gy achieved an 80% TCP in the population. Varying α between 0.160-0.118Gy(-1) with GS, a GTV and CTV dose of 80Gy and 70Gy also gave an 80% TCP. Considering only N0, our simulations suggest that a GTV-CTV dose differentiation of 7Gy would not compromise TCP of the patient population. When assuming an increased radiosensitivity with lower GS, a further dose differentiation of 10Gy might be feasible.